SCHEMBL3071607

SCHEMBL3071607

FCc1[c]ccc(CF)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10509760 0.76
SCHEMBL16333875 0.74
SCHEMBL9529183 0.74
SCHEMBL5773093 0.74
SCHEMBL5179873 0.70
SCHEMBL1043281 0.69
SCHEMBL4586792 0.67
SCHEMBL11004269 0.67 PRSS1 (0.33)
SCHEMBL311359 0.67 TRPA1 (0.38)
SCHEMBL25151 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018003-B2 Substituted pyrimidines as matrix metalloproteinase-9 hemopexin domain inhibitors THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-06-25 US disclosed
US-20210309616-A1 SUBSTITUTED QUINAZOLINES AS MATRIX METALLOPROTEINASE-9 HEMOPEXIN DOMAIN INHIBITORS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2021-10-07 US disclosed
CN-113038954-A Combination for treating cancer 日东电工株式会社 2021-06-25 CN disclosed
US-11040947-B2 Substituted quinazolines as matrix metalloproteinase-9 hemopexin domain inhibitors THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2021-06-22 US disclosed
US-10844006-B2 Trisamide compounds and compositions comprising the same MILLIKEN & COMPANY (US) 2020-11-24 US disclosed
EP-3426639-A1 TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME Milliken & Company (US) 2019-01-16 EP disclosed
US-20170260129-A1 TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME MILLIKEN & CO (US) 2017-09-14 US disclosed
WO-2017156099-A1 TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME MILLIKEN & COMPANY (US) 2017-09-14 WO disclosed
US-7790793-B2 Amide nucleating agent compositions CIBA SPECIALTY CHEM. CORP. (US) 2010-09-07 US disclosed
US-20090062358-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS CANO IVAN COLLADO 2009-03-05 US disclosed
CN-1479728-A Peroxisome proliferator activated receptor alpha agonists 2004-03-03 CN disclosed
US-5639882-A CHEMICAL INTERMEDIATES FOR FORMING VIRICIDES INHIBITING LENTIVIRUSES G. D. SEARLE & CO. (US) 1997-06-17 US disclosed
US-5637707-A STEREOSELECTIVELY ADDING ORGANONETALLIC REAGENT BY NUCLEOPHILIC ADDITION TO KETONE COMPOUND G. D. SEARLE & CO. (US) 1997-06-10 US disclosed
EP-0566556-B1 2-Substituted tertiary carbinol derivatives of 1,5-iminosugars as antiviral compounds SEARLE & CO (US) 1996-07-03 EP disclosed
US-5530132-A VIRICIDES, HIV VIRUS G. D. SEARLE & CO. (US) 1996-06-25 US disclosed
US-5523406-A STEREOSPECIFIC ALKYLATION BY NUCLEOPHILIC ADDITION AT C-2 WITH A GRIGNARD REAGENT G. D. SEARLE & CO. (US) 1996-06-04 US disclosed
US-5502193-A VIRICIDES FOR AIDS G. D. SEARLE & CO. (US) 1996-03-26 US disclosed
US-5350854-A AIDS treatment G. D. SEARLE & CO. (US) 1994-09-27 US disclosed
US-5258518-A Antiviral agents, anti-HIV activity G. D. SEARLE & CO. (US) 1993-11-02 US disclosed
EP-0566556-A1 2-Substituted tertiary carbinol derivatives of 1,5-iminosugars as antiviral compounds G.D. Searle &amp; Co. (US) 1993-10-20 EP disclosed